��������

Bihua Chen is the founder of Cormorant Asset Management, LP (“Cormorant”), an investment firm focused on innovative biotech, medtech and life science companies with assets under management of over $3bn. Ms. Chen manages Cormorant’s public fund as well as its private funds. Prior to founding Cormorant, Ms. Chen managed a separately managed account focused on the healthcare sector as a sub-adviser to a large, multi-strategy hedge fund based in New York. Ms. Chen obtained an MBA from the Wharton School of Business and a Master of Science, Molecular Biology, from the Graduate School of Biomedical Science at Cornell Medical College. Ms. Chen also holds a Bachelor of Science degree in Genetics and Genetic Engineering from Fudan University, Shanghai, China.